Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2026-08-06 17:20:06 ET · period of report 2026-08-04 · accession 0001808968-26-000017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-06 17:20 | 2026-08-04 | PTCT | Klein Matthew B. | CEO, Dir | S - Sale | $68.57 | -10.3K | 383.9K | -3% | -$705.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-04 | S | D | 10,292 | $68.57 | 383,868 | D | — | — | (F1) Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of the 25,000 RSUs from an August 1, 2025 grant of 75,000 RSUs. (F2) Includes 162 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2026. |